Aprea Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2019 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aprea Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2019 to Q3 2024.
  • Aprea Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2024 was 5.43M shares, a 45.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.43M +1.7M +45.4% Nov 7, 2024 10-Q 2024-11-07
Q2 2024 5.43M +1.7M +45.4% Aug 9, 2024 10-Q 2024-08-12
Q1 2024 5.43M +1.7M +45.5% Mar 26, 2024 10-K 2024-03-26
Q3 2023 3.74M -49.3M -92.9% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 3.74M -19.7M -84% Aug 10, 2023 10-Q 2023-08-10
Q1 2023 3.73M -18.2M -83% Mar 28, 2023 10-K 2023-03-30
Q3 2022 53M +31.5M +147% Nov 9, 2022 10-Q 2022-11-09
Q2 2022 23.4M +2.22M +10.5% Aug 10, 2022 10-Q 2022-08-12
Q1 2022 22M +787K +3.72% Mar 14, 2022 10-K/A 2022-05-02
Q3 2021 21.5M +278K +1.31% Nov 8, 2021 10-Q 2021-11-08
Q2 2021 21.2M 0 0% Aug 12, 2021 10-Q 2021-08-12
Q1 2021 21.2M +132K +0.63% Mar 16, 2021 10-K 2021-03-16
Q3 2020 21.2M +196K +0.94% Nov 6, 2020 10-Q 2020-11-06
Q2 2020 21.2M Aug 11, 2020 10-Q 2020-08-11
Q1 2020 21.1M Mar 27, 2020 10-K 2020-03-27
Q3 2019 21M Nov 13, 2019 10-Q 2019-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.